Search This Blog

Thursday, September 1, 2016

Amgen And Servier Extend Omecamtiv Mecarbil Collaboration In Chronic Heart Failure

Servier Provides Notice to Exercise Commercialization Option in Europe and Commonwealth of Independent States, Including Russia



Amgen - Investors - RSS Content

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.